Literature DB >> 26354202

Umbilical Cord Tissue Offers the Greatest Number of Harvestable Mesenchymal Stem Cells for Research and Clinical Application: A Literature Review of Different Harvest Sites.

C Thomas Vangsness1, Hal Sternberg2, Liam Harris3.   

Abstract

PURPOSE: Recent years have seen dramatic increases in the techniques used to harvest and isolate human mesenchymal stem cells. As the potential therapeutic aspects of these cells further develop, informative data on the differences in yields between tissue harvest sites and methods will become increasingly valuable. We collected and compared data on cell yields from multiple tissue harvest sites to provide insight into the varying levels of mesenchymal stem cells by tissue and offer primary and alternative tissue types for harvest and clinical application.
METHODS: The PubMed and Medline databases were searched for articles relating to the harvest, isolation, and quantification of human mesenchymal stem cells. Selected articles were analyzed for relevant data, which were categorized according to tissue site and, if possible, standardized to facilitate comparison between sites.
RESULTS: Human mesenchymal stem cell levels in tissue varied widely according to tissue site and harvest method. Yields for adipose tissue ranged from 4,737 cells/mL of tissue to 1,550,000 cells/mL of tissue. Yields for bone marrow ranged from 1 to 30 cells/mL to 317,400 cells/mL. Yields for umbilical cord tissue ranged from 10,000 cells/mL to 4,700,000 cells/cm of umbilical cord. Secondary tissue harvest sites such as placental tissue and synovium yielded results ranging from 1,000 cells/mL to 30,000 cells/mL.
CONCLUSIONS: Variations in allogeneic mesenchymal stem cell harvest levels from human tissues reflect the evolving nature of the field, patient demographic characteristics, and differences in harvest and isolation techniques. At present, Wharton's jelly tissue yields the highest concentration of allogeneic mesenchymal stem cells whereas adipose tissue yields the highest levels of autologous mesenchymal stem cells per milliliter of tissue. CLINICAL RELEVANCE: This comparison of stem cell levels from the literature offers a primer and guide for harvesting mesenchymal stem cells. Larger mesenchymal stem cell yields are more desirable for research and clinical application.
Copyright © 2015 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26354202     DOI: 10.1016/j.arthro.2015.03.014

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  24 in total

Review 1.  Therapeutic potential of mesenchymal stem cells for diabetes.

Authors:  Alvaro Moreira; Samuel Kahlenberg; Peter Hornsby
Journal:  J Mol Endocrinol       Date:  2017-07-24       Impact factor: 5.098

Review 2.  Recent Advances in Tissue Engineering Strategies for the Treatment of Joint Damage.

Authors:  Makeda K Stephenson; Ashley L Farris; Warren L Grayson
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

3.  Wharton's Jelly Derived Mesenchymal Stem Cells: Comparing Human and Horse.

Authors:  Barbara Merlo; Gabriella Teti; Eleonora Mazzotti; Laura Ingrà; Viviana Salvatore; Marina Buzzi; Giorgia Cerqueni; Manuela Dicarlo; Aliai Lanci; Carolina Castagnetti; Eleonora Iacono
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

Review 4.  Stem Cell Considerations for the Clinician.

Authors:  Karen A Hasty; Hongsik Cho
Journal:  Phys Med Rehabil Clin N Am       Date:  2016-11       Impact factor: 1.784

Review 5.  Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases.

Authors:  Milena B P Soares; Renata G J Gonçalves; Juliana F Vasques; Almir J da Silva-Junior; Fernanda Gubert; Girlaine Café Santos; Thaís Alves de Santana; Gabriela Louise Almeida Sampaio; Daniela Nascimento Silva; Massimo Dominici; Rosalia Mendez-Otero
Journal:  Front Mol Neurosci       Date:  2022-06-16       Impact factor: 6.261

6.  A randomized, controlled study to evaluate the efficacy of intra-articular, autologous adipose tissue injections for the treatment of mild-to-moderate knee osteoarthritis compared to hyaluronic acid: a study protocol.

Authors:  Ian A Jones; Melissa Wilson; Ryan Togashi; Bo Han; Austin K Mircheff; C Thomas Vangsness
Journal:  BMC Musculoskelet Disord       Date:  2018-10-24       Impact factor: 2.362

7.  Transplantation of umbilical cord mesenchymal stem cells via different routes in rats with acute liver failure.

Authors:  Sheng Zheng; Juan Yang; Jinhui Yang; Yingmei Tang; Qinghua Shao; Ling Guo; Qinghua Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

8.  Elevation of Peripheral Blood CD34+ and Platelet Levels After Exercise With Cooling and Compression.

Authors:  Mark C Callanan; Kevin D Christensen; Hillary A Plummer; Johnny Torres; Adam W Anz
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-02-22

Review 9.  Adipose Tissue and Mesenchymal Stem Cells: State of the Art and Lipogems® Technology Development.

Authors:  Carlo Tremolada; Valeria Colombo; Carlo Ventura
Journal:  Curr Stem Cell Rep       Date:  2016-07-13

10.  Evaluation of immediate and short-term efficacy of DualStim therapy with and without intracavernosal umbilical cord-derived Wharton's jelly in patients with erectile dysfunction: Study protocol for a randomized controlled trial.

Authors:  Ashim Gupta; Hugo C Rodriguez; Kristin Delfino; Howard J Levy; Saadiq F El-Amin; Richard Gaines
Journal:  Contemp Clin Trials Commun       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.